NLRP1 and adrenal cortex carcinoma: Moreover, there was a correlation between NLRP1 downregulation and adverse PFS in ACC (p = 8.8e‐06, HR = 0.24), CHOL (p = 0.017, HR = 0.33), HNSC (p = 0.0047, HR = 0.70), LUAD (p = 0.023, HR = 0.75), and SKCM (p = 0.023, HR = 0.77), while its upregulation was linked to worse PFS in Brain Lower Grade Glioma (LGG) (p = 0.0083, HR = 1.43), PRAD (p = 0.02, HR = 1.60), and Stomach Adenocarcinoma (STAD) (p = 0.018, HR = 1.40).